CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-15 | McKenzie Paul EVP Pharmaceutical Oper & Tech | Shares withheld for taxes | −643 | $332.87 | $214K | 7,324.63 |
| 2019-02-15 | McKenzie Paul EVP Pharmaceutical Oper & Tech | Option exercise · Restricted Stock Unit | −1,448 | 3,226 | ||
| 2019-02-15 | McKenzie Paul EVP Pharmaceutical Oper & Tech | Other disposition · Restricted Stock Unit | −888 | 2,338 | ||
| 2019-02-15 | Ehlers Michael D EVP, Research and Development | Option exercise | +1,685 | 8,526.17 | ||
| 2019-02-15 | Ehlers Michael D EVP, Research and Development | Shares withheld for taxes | −749 | $332.87 | $249K | 7,777.17 |
| 2019-02-15 | Ehlers Michael D EVP, Research and Development | Option exercise · Restricted Stock Unit | −1,685 | 3,757 | ||
| 2019-02-15 | Ehlers Michael D EVP, Research and Development | Other disposition · Restricted Stock Unit | −1,033 | 2,724 | ||
| 2019-02-15 | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. | Option exercise | +1,685 | 28,776 | ||
| 2019-02-15 | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. | Shares withheld for taxes | −749 | $332.87 | $249K | 28,027 |
| 2019-02-15 | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. | Option exercise · Restricted Stock Unit | −1,685 | 3,757 | ||
| 2019-02-15 | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. | Other disposition · Restricted Stock Unit | −1,033 | 2,724 | ||
| 2019-02-14 | Posner Brian S Director | Gift | −315 | 6,895 | ||
| 2019-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise | +6,899 | 16,267.27 | ||
| 2019-02-12 | Vounatsos Michel Chief Executive Officer | Shares withheld for taxes | −2,622 | $319.43 | $838K | 13,645.27 |
| 2019-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise · Restricted Stock Unit | −6,899 | 29,421 | ||
| 2019-02-12 | Vounatsos Michel Chief Executive Officer | Other disposition · Restricted Stock Unit | −5,205 | 24,216 | ||
| 2019-02-12 | Vounatsos Michel Chief Executive Officer | Grant or award · Restricted Stock Unit | +37,570 | 37,570 | ||
| 2019-02-12 | Sandrock Alfred EVP, Chief Medical Officer | Option exercise | +1,104 | 7,732.19 | ||
| 2019-02-12 | Sandrock Alfred EVP, Chief Medical Officer | Shares withheld for taxes | −358 | $319.43 | $114K | 7,374.19 |
| 2019-02-12 | Sandrock Alfred EVP, Chief Medical Officer | Shares withheld for taxes | −588 | $319.43 | $188K | 6,786.19 |
Page 51 of 61 · 1,204 trades